Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Clinical trial Open access Oct 2026

Evaluating a multi-vaccine respiratory immunization strategy involving SARS-CoV-2, pneumococcal, and influenza vaccines in adults: A randomized, open-label, multicenter, controlled, non-inferiority Phase IV trial in China

ABSTRACT Co-administration of vaccines targeting multiple respiratory pathogens may enhance coverage and streamline adult immunization programs. We conducted a randomized, multicentre, open-label Phase IV trial registered at Chinese Clinical Trial Registry (ChiCTR2100046227) in China to evaluate the immunogenicity and...

Xuan-Wen Shi, Sha-Sha Han, Cong Wu et al. · 0 citations
Clinical trial Open access Sep 2026

Immunogenicity and safety of a single dose of adjuvanted RSVPreF3 vaccine in adults ≥60 years of age in China: results from a phase 3 immunobridging trial

A single dose of adjuvanted RSVPreF3 was immunogenic and well tolerated in Chinese adults aged ≥60 years, supporting the extrapolation of global efficacy and a favorable benefit-risk profile in this population.

Xiang Guo, Gui-Jun Ning, D. Bi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.